scholarly article | Q13442814 |
P2093 | author name string | Qi Wang | |
S Stoney Simons | |||
Ying Huang | |||
John A Blackford | |||
Sehyung Cho | |||
Liang-Nian Song | |||
P2860 | cites work | The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes | Q40781028 |
P433 | issue | 6 | |
P304 | page(s) | 1376-1395 | |
P577 | publication date | 2004-03-11 | |
P1433 | published in | Molecular Endocrinology | Q3319475 |
P1476 | title | Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors | |
P478 | volume | 18 |
Q37333813 | A conserved protein motif is required for full modulatory activity of negative elongation factor subunits NELF-A and NELF-B in modifying glucocorticoid receptor-regulated gene induction properties |
Q37701748 | A kinase-independent activity of Cdk9 modulates glucocorticoid receptor-mediated gene induction |
Q38317726 | A novel principle for partial agonism of liver X receptor ligands. Competitive recruitment of activators and repressors |
Q52624565 | An Approach to Greater Specificity for Glucocorticoids. |
Q36492875 | Binding of the N-terminal region of coactivator TIF2 to the intrinsically disordered AF1 domain of the glucocorticoid receptor is accompanied by conformational reorganizations |
Q35185226 | Circadian CLOCK-mediated regulation of target-tissue sensitivity to glucocorticoids: implications for cardiometabolic diseases |
Q24633922 | Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease |
Q42724158 | Cyclic changes in the expression of p57(kip2) in human endometrium and its regulation by steroid hormones in endometrial stromal cells in vitro. |
Q36510988 | Differential modulation of glucocorticoid and progesterone receptor transactivation |
Q97890320 | Dissecting transcriptional amplification by MYC |
Q38432674 | Epigenetic landscapes reveal transcription factors that regulate CD8+ T cell differentiation. |
Q35073612 | Glucocorticoid receptor alpha isoform-selective regulation of antiapoptotic genes in osteosarcoma cells: a new mechanism for glucocorticoid resistance. |
Q34311390 | Glucocorticoid receptor cofactors as therapeutic targets |
Q37020166 | Glucocorticoid receptor physiology |
Q46263546 | Hemisuccinate of 21-hydroxy-6,19-epoxyprogesterone: a tissue-specific modulator of the glucocorticoid receptor |
Q37485010 | Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology |
Q36436018 | Identification of location and kinetically defined mechanism of cofactors and reporter genes in the cascade of steroid-regulated transactivation |
Q37841160 | Illuminating intracellular signaling and molecules for single cell analysis |
Q35168034 | In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancer |
Q33719222 | Insights on glucocorticoid receptor activity modulation through the binding of rigid steroids |
Q36419269 | Kinetically Defined Mechanisms and Positions of Action of Two New Modulators of Glucocorticoid Receptor-regulated Gene Induction |
Q35069559 | Ligand binding domain mutations of the glucocorticoid receptor selectively modify the effects with, but not binding of, cofactors |
Q37496703 | Minireview: dynamic structures of nuclear hormone receptors: new promises and challenges |
Q37143831 | Modulation of transcription parameters in glucocorticoid receptor-mediated repression. |
Q37183596 | Mutations of glucocorticoid receptor differentially affect AF2 domain activity in a steroid-selective manner to alter the potency and efficacy of gene induction and repression |
Q38409573 | Nuclear compartmentalization of N-CoR and its interactions with steroid receptors |
Q28115180 | PA1 protein, a new competitive decelerator acting at more than one step to impede glucocorticoid receptor-mediated transactivation |
Q60931261 | Potential Dissociative Glucocorticoid Receptor Activity for Protopanaxadiol and Protopanaxatriol |
Q21296830 | Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages |
Q33821604 | Research resource: modulators of glucocorticoid receptor activity identified by a new high-throughput screening assay |
Q35641879 | STAMP, a novel predicted factor assisting TIF2 actions in glucocorticoid receptor-mediated induction and repression |
Q26825916 | Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds |
Q36333338 | Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease |
Q36635944 | Sexually dimorphic actions of glucocorticoids provide a link to inflammatory diseases with gender differences in prevalence |
Q39416778 | Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT) regulates glucocorticoid action in adipocytes |
Q57112147 | Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR |
Q37621100 | Targeting nuclear receptors with marine natural products |
Q38319514 | The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: potential clinical implications |
Q37732566 | The ability of thyroid hormone receptors to sense t4 as an agonist depends on receptor isoform and on cellular cofactors |
Q33983786 | The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists |
Q27684737 | The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism |
Q42818488 | The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis. |
Q35250623 | The road less traveled: new views of steroid receptor action from the path of dose-response curves |
Q42204745 | Theory of partial agonist activity of steroid hormones |
Q36559964 | Understanding stress through the genome. |
Q34795516 | What goes on behind closed doors: physiological versus pharmacological steroid hormone actions |
Search more.